TERNS PHARMACEUTICALS INC (TERN) Stock Income Statement
NASDAQ:TERN - Nasdaq - US8808811074 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 1.00M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Operating Expenses | 103.85M | 101.87M | 102.56M | 62.03M | 50.86M | |||
| Research and Development | 70.25M | 70.11M | 63.50M | 39.62M | 31.31M | |||
| Selling, General, and Administrative Expenses | 33.61M | 31.76M | 39.06M | 22.41M | 19.55M | |||
| Operating Income | -103.85M | -101.87M | -102.56M | -62.03M | -49.86M | |||
| Interest Income/Expense | 13.75M | 13.29M | 12.90M | 2.11M | 170.00K | |||
| Other Income/Expense | -35.00K | -11.00K | -314.00K | -70.00K | 40.00K | |||
| Income Before Taxes | -90.14M | -88.59M | -89.97M | -59.99M | -49.65M | |||
| Income Tax | 251.00K | 260.00K | 239.00K | 360.00K | 510.00K | |||
| Net Income | -90.39M | -88.85M | -90.21M | -60.35M | -50.16M | |||
| EBITDA | -102.87M | -100.97M | -101.68M | -61.55M | -49.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.09 | -1.12 | -1.27 | -1.67 | -2.21 | |||
| Non GAAP EPS | -1.09 | -1.13 | -1.27 | -1.83 | -2.34 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | -5016.00% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | -4986.00% | |||
All data in USD